An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: Report of three cases

Article

Abstract: In COVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the di

Palabras claves:

CD6 molecule, coronavirus 2, covid-19, cytokine-release syndrome, IL-6, Itolizumab, Monoclonal antibody, SARS-COV-2

Autores:

Añe-Kouri A.L., Berrio J., Caballero A., Caballero J.A., Cepeda M., Cervantes J.B., Figueredo C., Filgueira L.M., Herrera C., Leon K., Lorenzo G., Lovelle O.A., Mazorra Z., Ramos M., Saavedra Hernández D., Sánchez N., Tania Crombet

Fuentes:

scopus